The polycystic ovary syndrome (PCOS) is a condition in which the ovaries accumulate tiny "cysts" (actually little follicles, two to five millimeters in diameter, each of which contains an egg)
The polycystic ovary syndrome (PCOS) is a condition in which the ovaries accumulate tiny "cysts" (actually little follicles, two to five millimeters in diameter, each of which contains an egg) instead of the follicles growing and going on to ovulate they stall and secrete male hormone into the blood. Ovulation can be rare without the help of medications. In some women, there will be a long history of irregular periods and, perhaps, an increase in facial and body hair caused by more than the normal amount of male hormone in the blood. There are estimates that about 20 percent of all women have mild polycystic ovaries (PCO). It's probably genetic - often coming down the male side of the family.
One problem physicians have had in making the diagnosis of PCOS is that there is no universally accepted definition for this disease. Most reproductive endocrinologists, however, require the presence of hyperandrogenism (excessive "male" hormones) and chronic anovulation (infrequent or absent ovulation resulting in irregular menstrual cycles) to make the diagnosis. Others require the appearance of polycystic ovaries on vaginal ultrasound examination.
Because other disorders of the ovary, pituitary gland and adrenal gland can mimic the symptoms and appearance of PCOS, these disorders should be excluded before an accurate diagnosis of PCOS can be made. When a woman is not trying to get pregnant, oral contraceptive pills are good treatments: they stop follicles and male-hormone-producing tissue from accumulating, stops complications such as abnormal hair growth from taking place, gives regular periods, provides contraception, and protects future fertility.
When attempting pregnancy, the drug Clomiphene citrate (Clomid or Serophene) is often the first choice to induce ovulation. If Clomiphene doesn't work then physicians often use injectable medications such as Pergonal, Humegon, Gonal-F, Follistim, and Repronex. Using the injectable medications to induce ovulation patients with PCOS is often complicated, since in some cases, up to 10 or 20 follicles will respond and try to ovulate. It is important that if this happens, the cycle be cancelled, and the next month be started with lower doses of medications.
Finally, there has recently been a strong association uncovered between PCOS and Insulin resistance (part of a spectrum that includes Diabetes Mellitus). Weight reduction will greatly improve not only insulin resistance, but also help regulate menstrual cycles, improve fertility and reduce male hormone levels. In addition, weight loss will lower the risks of coronary artery disease and uterine cancer. Recently, two medications, Metformin and Troglitazone, have been shown to effectively improve insulin sensitivity in women with PCOS and help regulate menstrual cycles. They can be considered as an adjunct to weight loss and exercise in some patients, and may improve a patient's response to fertility medications.
It is important to remember that PCOS is a complicated disease with many different presentations. In most patients, however, it can be managed safely and effectively to help patients improve their fertility and lead healthier lifestyles.
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Shared genetics found between anti-Müllerian hormone and age at menopause
December 4th 2024In a recent study, an inverse relationship was discovered between anti-Müllerian hormone levels and early menopause, highlighting the need to develop interventions for fertility preservation based on genetics.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More